In a separate study, hyperphosphorylation of RPS6 (S235/236) or the ratio of p-RPS6 to t-RPS6 was reported to be a predictive marker for survival of patients with NSCLC [38]. This evidence concerns the gene RPS6 and non-small cell lung carcinoma.